Getting human gene therapy to work

Journal of Cellular Biochemistry

Volumn 58, Issue 4, 1995, Pages 416-423

  Stewart, F Marc ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; DNA; RECOMBINANT DNA; VIRUS VECTOR;

CELL ISOLATION; CLINICAL PROTOCOL; ENZYME DEFICIENCY; GENE THERAPY; GENE TRANSFER; HISTORY OF MEDICINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMAL; CYTOKINES; DNA; GENE THERAPY; GENE TRANSFER TECHNIQUES; HIV; HUMAN; RETROVIRIDAE; STEM CELLS; TRANSDUCTION, GENETIC;

EID: 0029144431     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.240580404     Document Type: Article

References (75)

1. September 14, 1990: the beginning [editorial]
2. Gene transfer into hematopoietic stem cells
3. Treatment of genetic defects n hematopoietic cell function by gene transfer
4. Gene therapy for cancer [see comments]
5. Human gene therapy comes of age
6. Safety ussues related to retroviral‐Mediated gene transfer in humans
7. Evidence that the packaging singnal of moloney Murine leukemia virus extends into the gag region
8. Retroviral RNA packaging: sequirrements and implications
9. Retrovirus packaging cells
10. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production
11. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates
12. Retrovirus purification: method that conserves envelope glycoprotein and maximizes infectivity
13. Replication‐defective chimeric helper proviruses and factors affecting grneration of competent virus: Expression of moloney murine leukemia virus structural genes via te metallothionein promoter
14. Safe and efficient generation of reonbinant retroviruses with amphotropic and ecotropic host ranges
15. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer
16. Retroviral‐mediated gene therapy‐safety considerations and preclinical studies
17. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
18. Molecular lesions involved in the progression of a human breast cancer
19. Chromosome 17 deleions and p53 gane mutations in colorectal carcinomas
20. Mutations in Human breast cancer: an overview
21. p53: a frequent target for genetic abnormalities in lung cancer
22. Allelotype of colorectal carcinomas
23. Differential DNA sequence deletions from chromosomes 3, 11, 13, and 17 in squamous‐cell carcinoma, large‐cell carcinoma, and adenocarcinoma of the human lung
24. Expression of introduced genetic sequences in hematopoietic cells folloeing retroviralmediated gene transger
25. High‐efficiency gene transfer to human hematopoietic cells maintained in long‐term marrow culture (see comments)
26. Retroviral vector‐mediated transfer of the bacterialk neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro
27. Retrovirus‐mediated gene transfer to purified hemopoietic stem cells with long‐term lympho‐myelopoietic repopulating ability
28. Introduction of new genetic material into pluripotent haematopoietic stem cells of the mouse
29. Uncpvering the heterogeneity of hematopoietic repopulating cells [editorial]
30. Growth of human umbilical‐cord blood in longterm haemopoietic cultures [see commentsl]
31. Growth of human umbilical‐cord Blood in longterm haemopoietic cultures [see comments]
32. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus‐mediated gene transfer into hematopoietic stem cells
33. Stem Cell factor increases colony‐forming unit spleen number in vitro in synergy with interleukin‐6, and in vivo in SI/mice as single factor
34. Comperison of the effects of growth factors on retroviral vector‐mediated gene transfer and the proliferative status of human hematopoietic progenitor cells
35. Stromal Support enhances cell‐free retroviral vector transduction of human bond marrow long‐term culture‐initiaitng cells
36. Detection of Primitive Macrophage progenitor cells in mouse bone marrow
37. Effects of Endotoxin and extracts of pregnant mouse uterus on the recovery of hemopoiesis after 5‐fluorouracil
38. Most Primitive hematopoietic stem cells are stimulated to cycle rapidly after treactment with 5‐fluorouracil
39. Synergistic interactions between hematopoietic frowth factors as dtercted by in vitro mouse bone marrow colony formation
40. Stimulation of murine colony Formation by the combination of GM‐CSF and CSF‐1
41. Effects of rrSCF on multiple cytokine responsive HPP‐CFC generated from SCA + Lin‐ Murine Hematopoietic progenitors
42. Interleukin 6 enhancement of Interleu kin 3‐dependent proliferation of multipotential hemopoietic progenitors
43. Granulocyte colony‐stimulating factor enhances interleukin 3‐dependent proliferation of multipotential hemopoietic progenitors
44. Enhancement of murine hematopoiesis by synergistic interactions between stell factor (ligand for c‐kit), interleukin‐11 and other early acting factors in culture
45. Purification of pluriotent hemopoietic stem cells: past and present
46. Murine leukemia inhibitory factor enhances retroviral‐vector infection efficency of hematopoietic progenitors
47. Cloning of DNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells
48. Interleukin‐13 is a new human lymphokine regulating inflammatiry and immune responess
49. “Pure” human hematopoietic progenitors: permissive action of basic fibroblast growth factor
50. Basic fibroblast growth promotes the proliferation of human megakaryocyte progenitor cells
51. Basic fibroblast growth factor stimulates myelopoiesis in long trem human bone marrow cultures
52. Enhancement of the grafting efficiency of transplanted marroe cells by preincubation with interleukin‐3 and granulocyte‐macrophage colony stimulating factor
53. Stem cell factor increase colony‐forming unit‐spleen number in vitro in synergy with interleukin‐6, and in vivo in Sl/sld mice as a single factor
54. Suppressor cytokines and regulation of myclopoiesis. Biology and possible clinical uses
55. Demonstration of stem cell inhibition and myeloprotective effectss of SCI/rhMIP1 alpha in vivo
56. Enhancing and suppressing effects of recombinant murine macrophage inflammatory proteins on colony formation in vitro by bone marrow myeloid progenitor cells
57. The tetrapeptide AcSDKP, an inhibitor of the cell‐cycle status for human hematopoietic progenotors, has no effects on leukemiccells
58. Inhibitory effects of a synthetic pentapeptide on hemopoietic stem cells in vitro and vivo
59. Long term engraftment of normal and post 5‐fluorouracil murine marrow into normal nonmyeloablated mice [see comments]
60. Special proliferative sites are not needed for seeding and proliferation of transfused bone marroe cells in normal syngeneic mice
61. Y‐encoded species‐specific DNAin mice:evidence that the Ychromosome exists in two polymorphic forms in inbred strains
62. Brief report:donor‐derived long‐term multilineage hematopoiesis in a liver‐transplant recipient [see comments]
63. Multidrug resistance
64. The biochemistry of P‐glycoprotein‐mediated resistance, qannu
65. Expression and activity of P‐glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells
66. Transgenic mice that express the human multidrug ‐ resistance gene in bone marroe enable a rapid identification of agents that reverse drug resistance
67. Chemotherapy and chemosensitization of transgenic mice expressthe human multidrug resistance gene in bone marrow: efficency, potency, and toxicity
68. Selection of drug resistant bone marrow cells in vivo after retroviral transfer of human MDRI
69. A safe packaging line for genetransfer: separating viral genes on two differement plasmids